China Medicine (OTC: CHME)
$0.00
(50.0%)
$0.00
Price as of June 16, 2025, 3:19 p.m. ET
China Medicine Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
China Medicine Company Info
China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. Its products include shuangdan capsules, houerhuan anti-inflammatory capsules, shugan yipi granules, danggui tiaojing granules, huangzao granules, pingfeng shengmai capsules, danqi and naodesheng tablets. The company was founded on February 10, 2005 and is headquartered in Guangzhou, China.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.